<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The neuroprotective effect of the <z:chebi fb="0" ids="7542">neurotensin</z:chebi> analogue H-Lys-psi(CH2NH)Lys-Pro-Tyr<z:chebi fb="84" ids="32607">-Ile</z:chebi>-Leu-OH (JMV-449) was assessed in a mouse model of permanent distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Mice were injected with 0.6 nmol JMV-449 or vehicle i.c.v. immediately after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The core temperature declined by 6-7 degrees C after 30 min and the <z:hpo ids='HP_0002045'>hypothermia</z:hpo> persisted for 4-5 h </plain></SENT>
<SENT sid="3" pm="."><plain>JMV-449 treatment was able to reduce the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume significantly both at 24 h and 14 days after <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>No neuroprotective effect could be seen if the mice were kept normothermic after the JMV-449 treatment suggesting that the neuroprotective effect is mediated via the <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
</text></document>